Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study
Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, et al.
Life (2023) Vol. 13, Iss. 1, pp. 191-191
Open Access | Times Cited: 15

Showing 15 citing articles:

New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story
Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136336-136336
Closed Access | Times Cited: 30
Integrated in silico and in vitro exploration of the anti-VEGFR-2 activities of a semisynthetic xanthine alkaloid inhibiting breast cancer
Eslam B. Elkaeed, Hazem Elkady, Ahmed M. Khattab, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316146-e0316146
Open Access
New Theobromine Derivatives Inhibiting VEGFR-2: Design, Synthesis, Antiproliferative, Docking and Molecular Dynamics Simulations
Hazem A. Mahdy, Hazem Elkady, Mohammed S. Taghour, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 14, pp. 1233-1250
Closed Access | Times Cited: 14
Anti-virulence potential of patuletin, a natural flavone, against Staphylococcus aureus: In vitro and In silico investigations
Ahmed M. Metwaly, Moustafa M. Saleh, Bshra A. Alsfouk, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24075-e24075
Open Access | Times Cited: 5
Design, in silico studies and biological evaluation of novel chalcones tethered triazolo[3,4-a]isoquinoline as EGFR inhibitors targeting resistance in non-small cell lung cancer
Nesma Abdelaal, Mohamed A. Ragheb, Hamdi M. Hassaneen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
A Theobromine Derivative with Anticancer Properties Targeting VEGFR‐2: Semisynthesis, in silico and in vitro Studies
Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, et al.
ChemistryOpen (2023) Vol. 12, Iss. 10
Open Access | Times Cited: 8
Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2: in silico and in vitro evaluations
Mohammed A. Dahab, Hazem A. Mahdy, Hazem Elkady, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 8, pp. 4214-4233
Closed Access | Times Cited: 7
Visible-light promoted catalyst-free (VLCF) multi-component synthesis of spiro indolo-quinazolinone-pyrrolo[3,4-a]pyrrolizine hybrids: evaluation of in vitro anticancer activity, molecular docking, MD simulation and DFT studies
Safia Iqbal, Farhanaz, Roohi Roohi, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 6, pp. 3145-3165
Closed Access | Times Cited: 5
Design, synthesis, biological evaluation and computational studies of 4-Aminopiperidine-3, 4-dihyroquinazoline-2-uracil derivatives as promising antidiabetic agents
Ladan Baziar, Leila Emami, Zahra Rezaei, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFR WT , EGFR T790M , and EGFR L858R )
Mahmoud G. Abo Al-Hamd, Haytham O. Tawfik, Omeima Abdullah, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 3
New Theobromine Apoptotic Analogue with Anticancer Potential Targeting the EGFR Protein: Computational and In Vitro Studies
Ibrahim H. Eissa, Reda G. Yousef, Eslam B. Elkaeed, et al.
ACS Omega (2024) Vol. 9, Iss. 14, pp. 15861-15881
Open Access
Integration of 3D-QSAR, Molecular Docking, and Machine Learning Techniques for Rational Design of Nicotinamide-Based SIRT2 Inhibitors
Aleksandra Ilić, Nemanja Djoković, Teodora Djikić, et al.
Computational Biology and Chemistry (2024) Vol. 113, pp. 108242-108242
Closed Access
Identification of Potential Inhibitors of TGFβR1 for the treatment of Cancer through Structure‐based virtual screening and Molecular dynamics simulations
Saumya Rastogi, Shashank Shekher Mishra, Lakhveer Singh, et al.
Chemistry & Biodiversity (2024)
Closed Access
Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducers
Reda G. Yousef, Ibrahim H. Eissa, Hazem Elkady, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 24, pp. 2583-2598
Open Access
Computer-Assisted Drug Discovery of a Novel Theobromine Derivative as an EGFR Protein-Targeted Apoptosis Inducer
Ibrahim H. Eissa, Reda G. Yousef, Eslam B. Elkaeed, et al.
Evolutionary Bioinformatics (2023) Vol. 19
Open Access | Times Cited: 1
A new anticancer derivative of the natural alkaloid, theobromine, as an EGFR inhibitor and apoptosis inducer
Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, et al.
Theoretical Chemistry Accounts (2023) Vol. 143, Iss. 1
Closed Access | Times Cited: 1
Page 1

Scroll to top